Abstract:
"Attention Deficit Hyperactivity Disorder, usually known as ADHD, is a complex
neurodevelopmental disorder which is the most common psychological disorder in children
nowadays. This disorder can normally be identified in younger children and can present
symptoms in dissimilar patterns from child to child. These symptoms are rarely ever severe
but, if left undiagnosed and untreated, they could continue into the child’s adulthood
chronically. Therefore, it is vital to provide the child the right care and treatment as soon
as possible. This, however, is often not the case; due to social pressures or
misunderstanding of the child’s behavior or even lack of sufficient knowledge of ADHD,
the child’s condition is undiagnosed and thereby face the repercussions for the rest of their
lives.
The aim of the project is to identify and analyze obstacles that may prevent a child with
ADHD from getting the appropriate diagnosis and treatment and in so doing design,
develop and evaluate a proactive technological solution. The focus of the project is to
provide a pathway to avoid these obstacles faced by children with ADHD and their
families. Therefore, in order to design an effective solution, an analysis of numerous
literatures was done to gain knowledge about the obstacles and the optimal form of
treatment for the disorder. Medical professionals and public surveys were also conducted
to support the findings of the analyses.
Taking these findings into consideration, the idea of “Attental” was conceived and then
developed. Attental is a complete and proactive solution in the form of a mobile application
for the diagnosis and treatment of ADHD in children specifically aged 5 years and above,
that also allows progress tracking, mobile-consultation facilities and act as an educational
platform to educate the families of the diagnosed children which the condition.
The proposed solution was evaluated and highly regarded by expert and non-expert parties
when given to determine the success of the solution in terms of providing children with
ADHD with diagnoses and approved treatments."